British drugmaker’s new chief executive Luke Miels announces one of its biggest dealsBusiness live – latest updatesGSK’s new boss, Luke Miels, has struck one of the British drugmaker’s biggest deals, announcing the $10.6bn (£7.9bn) acquisition of a US cancer specialist…
British drugmaker’s new chief executive Luke Miels announces one of its biggest deals
GSK’s new boss, Luke Miels, has struck one of the British drugmaker’s biggest deals, announcing the $10.6bn (£7.9bn) acquisition of a US cancer specialist with two late-stage medications.
The FTSE 100 company is boosting its oncology portfolio by agreeing to buy Nuvalent, a Boston-based biotech that develops cancer drugs, including three for lung cancer. GSK will pay $124 a share in cash.
Follow today’s news liveGet our breaking news email, free app or daily news podcastAlbanese says Australia still impacted by Middle…
Lieutenant governor and attorney general advance but result signals decisive defeat for controversial Nancy MaceDonald Trump-backed Pamela Evette, South Carolina’s…
Hilton has worn many hats since he arrived in the US 14 years ago, and now faces steep odds of…
Leave a Reply